Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance

被引：0
|
作者：
Inyoung Lee
Jeremy D. Jokinen
Stephanie Y. Crawford
Gregory S. Calip
Ryan D. Kilpatrick
Todd A. Lee
机构：
[1] University of Illinois at Chicago,Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy
[2] Bristol-Myers Squibb Company,Center for Pharmacoepidemiology and Pharmacoeconomics Research
[3] University of Illinois at Chicago,undefined
[4] Flatiron Health,undefined
[5] Inc.,undefined
[6] AbbVie Inc.,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2021年 / 55卷
关键词：
vigiGrade; Patient support program; Weighting; Completeness; Pharmacovigilance; Well documented;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：142 / 151
页数：9
相关论文
共 50 条
  • [31] Pharmacovigilance in Australia: how do adverse event reports from clinicians contribute to medicine and vaccine safety?
    Greenbaum, Deborah
    Cheung, Stephanie
    Turner, Claire
    Mackinnon, Fiona
    Larter, Claire
    AUSTRALIAN PRESCRIBER, 2024, 47 (06) : 186 - 191
  • [32] Thoughts on Signal Detection in Pharmacovigilance
    Saad A.W. Shakir
    Drug Safety, 2007, 30 : 603 - 606
  • [33] Data Mining for Signal Detection of Adverse Event Safety Data
    Chen, Hung-Chia
    Tsong, Yi
    Chen, James J.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (01) : 146 - 160
  • [34] Principles of signal detection in pharmacovigilance
    Meyboom, RHB
    Egberts, ACG
    Edwards, IR
    Hekster, YA
    deKoning, FHP
    Gribnau, FWJ
    DRUG SAFETY, 1997, 16 (06) : 355 - 365
  • [35] Principles of Signal Detection in Pharmacovigilance
    Ronald H. B. Meyboom
    Antoine C. G. Egberts
    I. Ralph Edwards
    Yechiel A. Hekster
    Fred H. P. de Koning
    Frank W. J. Gribnau
    Drug Safety, 1997, 16 : 355 - 365
  • [36] Thoughts on signal detection in pharmacovigilance
    Shakir, Saad A. W.
    DRUG SAFETY, 2007, 30 (07) : 603 - 606
  • [37] Evaluation of Bayesian Methodology for Use in Manufacturing Related Automated Signal Detection with Batch(lot) Specific Adverse Event Reports
    Kellier, Nicole
    Lipkovich, Ilya
    Hornbuckle, Ken
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 208 - 209
  • [38] Adverse events to radiopharmaceuticals: evaluation of French pharmacovigilance reports
    Langlet, S.
    Bres, V.
    Couret, I.
    Hillaire-Buys, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 32 - 32
  • [39] Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry
    C. Fernandez-Fernandez
    E. Lázaro-Bengoa
    E. Fernández-Antón
    L. Quiroga-González
    D. Montero Corominas
    European Journal of Clinical Pharmacology, 2020, 76 : 1175 - 1181
  • [40] Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system
    Huang, Qing
    Wu, Yuanbin
    Li, Huimin
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 221 - 231
12345